Role of Acid Suppression in the Development and Progression of Dysplasia in Patients with Barrett’s Esophagus

Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus

(2010) Dang M. Nguyen et al.   GASTROENTEROLOGY

Elevated Serum Gastrin Is Associated With a History of Advanced Neoplasia in Barrett's Esophagus

(2009) Judy S Wang et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

In Benign Barrett's Epithelial Cells, Acid Exposure Generates Reactive Oxygen Species That Cause DNA Double-Strand Breaks

(2009) H. Y. Zhang et al.   CANCER RESEARCH

Medication Usage and the Risk of Neoplasia in Patients With Barrett's Esophagus

(2009) Dang M. Nguyen et al.   Clinical Gastroenterology and Hepatology

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis

(2009) Marjolein Sikkema et al.   Clinical Gastroenterology and Hepatology

Proton pump inhibitor influence on reflux in Barrettʼs oesophagus

(2009) Anne Smythe et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Long-term proton pump induced hypergastrinaemia does induce lineage-specific restitution but not clonal expansion in benign Barrett's oesophagus in vivo

(2009) J. A. Obszynska et al.   GUT

The Molecular Pathogenesis of Barrett’s Esophagus: Common Signaling Pathways in Embryogenesis Metaplasia and Neoplasia

(2009) Jeffrey H. Peters et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Prevalence of Barrett’s Esophagus in Patients with or without GERD Symptoms: Role of Race, Age, and Gender

(2008) Xinqing Fan et al.   DIGESTIVE DISEASES AND SCIENCES

Treatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagus

(2008) Piers A. C. Gatenby et al.   DISEASES OF THE ESOPHAGUS